Nieto R Luisa Maria, Mehaffy Carolina, Creissen Elizabeth, Troudt JoLynn, Troy Amber, Bielefeldt-Ohmann Helle, Burgos Marcos, Izzo Angelo, Dobos Karen M
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America.
School of Veterinary Science, University of Queensland, Gatton, Queensland, Australia; Australian Infectious Diseases Research Centre, University of Queensland, St Lucia, Queensland, Australia.
PLoS One. 2016 Nov 28;11(11):e0166807. doi: 10.1371/journal.pone.0166807. eCollection 2016.
In the last decade, there were 10 million new tuberculosis cases per year globally. Around 9.5% of these cases were caused by isoniazid resistant (INHr) Mycobacterium tuberculosis (Mtb) strains. Although isoniazid resistance in Mtb is multigenic, mutations in the catalase-peroxidase (katG) gene predominate among the INHr strains. The effect of these drug-resistance-conferring mutations on Mtb fitness and virulence is variable. Here, we assessed differences in bacterial growth, immune response and pathology induced by Mtb strains harboring mutations at the N-terminus of the katG gene. We studied one laboratory and one clinically isolated Mtb clonal pair from different genetic lineages. The INHr strain in each pair had one and two katG mutations with significantly reduced levels of the enzyme and peroxidase activity. Both strains share the V1A mutation, while the double mutant clinical INHr had also the novel E3V katG mutation. Four groups of C57BL/6 mice were infected with one of the Mtb strains previously described. We observed a strong reduction in virulence (reduced bacterial growth), lower induction of proinflammatory cytokines and significantly reduced pathology scores in mice infected with the clinical INHr strain compared to the infection caused by its INHs progenitor strain. On the other hand, there was a subtle reduction of bacteria growth without differences in the pathology scores in mice infected with the laboratory INHr strain. Our results also showed distinct alkyl-hydroperoxidase C (AhpC) levels in the katG mutant strains, which could explain the difference in the virulence profile observed. The difference in the AhpC levels between clonal strains was not related to a genetic defect in the gene or its promoter. Cumulatively, our results indicate that the virulence, pathology and fitness of INHr strains could be negatively affected by multiple mutations in katG, lack of the peroxidase activity and reduced AhpC levels.
在过去十年中,全球每年有1000万新增结核病病例。其中约9.5%的病例由耐异烟肼(INHr)的结核分枝杆菌(Mtb)菌株引起。尽管Mtb对异烟肼的耐药性是多基因的,但过氧化氢酶-过氧化物酶(katG)基因突变在INHr菌株中占主导地位。这些赋予耐药性的突变对Mtb的适应性和毒力的影响各不相同。在此,我们评估了katG基因N端发生突变的Mtb菌株在细菌生长、免疫反应和病理学方面的差异。我们研究了来自不同遗传谱系的一对实验室分离株和一对临床分离的Mtb克隆株。每对中的INHr菌株分别有一个和两个katG突变,酶水平和过氧化物酶活性显著降低。两种菌株都有V1A突变,而双突变临床INHr菌株还具有新的E3V katG突变。将四组C57BL/6小鼠分别感染上述一种Mtb菌株。我们观察到,与感染其敏感祖代菌株相比,感染临床INHr菌株的小鼠毒力大幅降低(细菌生长减少),促炎细胞因子诱导水平较低,病理学评分显著降低。另一方面,感染实验室INHr菌株的小鼠细菌生长略有减少,但病理学评分没有差异。我们的结果还显示,katG突变菌株中的烷基过氧化氢酶C(AhpC)水平不同,这可以解释所观察到的毒力特征差异。克隆菌株之间AhpC水平的差异与该基因或其启动子的遗传缺陷无关。总体而言,我们的结果表明,katG基因的多个突变、过氧化物酶活性缺乏和AhpC水平降低可能会对INHr菌株的毒力、病理学和适应性产生负面影响。